In conclusion, our study discovered that EA could improve PD symptoms in mice by activating PI3K/Akt and inhibiting NF-κB and MAPK signal pathways, inhibiting neuroinflammation and playing a neuroprotective role (Figure 9). This evidence concerns the gene NFKB1 and Parkinson disease.